Invesco Ltd. Mustang Bio, Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.58 - $1.13 $12,716 - $24,775	-21,925 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$0.73 - $1.81 $379 - $941	520 Added 2.43%	21,925 $22,000
Q4 2021 Feb 14, 2022	SELL	$1.66 - $2.64 $778 - $1,238	-469 Reduced 2.14%	21,405 $36,000
Q3 2021 Nov 15, 2021	SELL	$2.58 - $3.36 $2,118 - $2,758	-821 Reduced 3.62%	21,874 $59,000
Q2 2021 Aug 17, 2021	BUY	$2.7 - $3.81 $2,376 - $3,352	880 Added 4.03%	22,695 $75,000
Q1 2021 May 17, 2021	BUY	$3.02 - $5.16 $4,252 - $7,265	1,408 Added 6.9%	21,815 $72,000
Q4 2020 Feb 16, 2021	BUY	$2.66 - $4.18 $54,282 - $85,301	20,407 New	20,407 $77,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $20M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.